Physician profile
Allen Chen
NPI 1992810790
$9,074.25
in general payments reported to CMS, 2019-2025
28 companies · $1,831 in 2025
The $1,831 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,508 · 2020: $793 · 2021: $1,017 · 2022: $1,326 · 2023: $1,297 · 2024: $1,303 · 2025: $1,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,430.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,739.12 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $820.68 | 2023-2025 | Intellis Adaptivestim, Mazor X System, Vanta Adaptivestim |
| Stimwave Technologies Incorporated | $814.50 | 2019-2022 | |
| Abbott Laboratories | $717.52 | 2019-2024 | Eterna |
| Spr Therapeutics, INC | $654.14 | 2019-2025 | Sprint Pns System |
| Integra Lifesciences Corporation | $485.10 | 2019-2021 | |
| Mml US, INC. | $407.93 | 2023-2025 | Reactiv8 |
| Nalu Medical, INC. | $402.68 | 2022 | |
| Stryker Corporation | $389.74 | 2021-2025 | Optablate, Omnicurve, Spinejack |
| Vertos Medical, INC. | $359.18 | 2022-2024 | Mild Device Kit |
| Curonix LLC | $326.02 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Innovation Technologies INC | $307.48 | 2021-2024 | Irrisept |
| Stratus Medical, LLC | $173.68 | 2023 | Nimbus |
| Saol Therapeutics INC. | $165.00 | 2021 | |
| Merz Pharmaceuticals, LLC | $152.55 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $148.79 | 2019 | |
| Relievant Medsystems, INC. | $146.03 | 2021-2022 | |
| Biotronik Nro, INC. | $131.96 | 2023 | Biotronik |
| Nevro Corp. | $128.96 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2022 | |
| Merz North America, INC. | $125.00 | 2020 | |
| Spinal Simplicity, LLC | $90.84 | 2021 | |
| Team_makena_llc | $84.73 | 2019 | |
| Siemens Medical Solutions USA, INC. | $67.64 | 2022 | |
| Avanos Medical | $48.27 | 2020 | |
| Axonics, INC. | $30.27 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.58 | 2023 | Jardiance |
| Avita Medical Americas, LLC | $13.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.